Accordingly, NK-1R antagonists (e.g., aprepitant) have been suggested to treat tumors, including gliomas [62], and hence, the substance P/NK-1R system is a promising antitumor target to treat gliomas. The gene discussed is TAC1; the disease is central nervous system cancer.